NDC 11523-0122-01 - MiraLAX Orange Flavor
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11523-0122
- Requested NDC
- 11523-0122-01
- Package NDCs from labels
- 11523-0122-2, 11523-0122-1, 11523-0122-01
- Manufacturer
- Bayer HealthCare LLC.
- Effective date
- 2025-12-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MiraLAX ® Orange Flavor | Bayer HealthCare LLC. | 2025-12-04 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11523-0122-1 | MiraLAX Orange Flavor | 238 g in 1 BOTTLE | POWDER, FOR SOLUTION | 238 | 3 | |
| 11523-0122-2 | MiraLAX Orange Flavor | 119 g in 1 BOTTLE | POWDER, FOR SOLUTION | 119 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11523-0122 | MIRALAX ORANGE FLAVOR (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [BAYER HEALTHCARE LLC.] | 2 | Current NDC, 2 package rows | 20241208_0a5b2121-928f-8f49-e063-6394a90a8aaf.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GENTLELAX | POLYETHYLENE GLYCOL 3350 | Kroger Company | 2390b507-93d5-43a0-aa51-31ca4edd6b7f | 2024-07-03 | Warnings | ANDA090685 876193 G2M7P15E5P |
| careone clearlax | POLYETHYLENE GLYCOL 3350 | Retail Business Services, LLC | 2378b76d-dc5a-4ff1-ad48-9f3e0c31c6cd | 2024-05-19 | Warnings | ANDA090685 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | CHAIN DRUG MARKETING ASSOCIATION, INC. | 901a1918-87bb-47c2-a465-8c468c3a1ee5 | 2024-03-26 | Warnings | 876193 G2M7P15E5P |
| smoothlax | POLYETHYLENE GLYCOL 3350 | Walgreen Company | aeb5c32c-443e-4ea3-8e96-fed38225fdf3 | 2024-03-12 | Warnings | ANDA090685 876193 G2M7P15E5P |
| Topcare ClearLax | POLYETHYLENE GLYCOL 3350 | Topco Associates LLC | 02f81a86-bec5-4e8b-bddb-d463ae2ea9e9 | 2024-02-07 | Warnings | ANDA090685 876193 G2M7P15E5P |
| POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | Bryant Ranch Prepack | 66276671-0ccd-4c32-a697-31e679fce0e3 | 2024-02-06 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | BluePoint Laboratories | 02e36812-53c2-003b-e063-6394a90aed12 | 2024-01-31 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol 3350, NF Powder for Solution, Laxative | POLYETHYLENE GLYCOL 3350, NF POWDER FOR SOLUTION, LAXATIVE | LGM PHARMA SOLUTIONS, LLC | d78bead5-ff19-4d45-9003-ec131f1f5a13 | 2024-01-17 | Warnings | 876193 G2M7P15E5P |
| Welby ClearLax | POLYETHYLENE GLYCOL 3350 | Aldi, Inc | d64caba5-614f-4edc-bb47-ce4fed38ce45 | 2023-11-10 | Warnings | ANDA090685 876193 G2M7P15E5P |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 7a2d8dab-750f-43c1-933c-4169a840c60c | 2023-06-20 | Warnings, Adverse reactions | G2M7P15E5P |
| good sense clearlax | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | 9858edef-cdb2-4ac4-8e4b-ba0720a24e41 | 2023-06-01 | Warnings | ANDA090685 876193 G2M7P15E5P |
| dg health clearlax | POLYETHYLENE GLYCOL 3350 | Dolgencorp Inc | ffae36fd-2fb7-4afb-a7f8-29c700a477fb | 2023-05-04 | Warnings | ANDA090685 876193 G2M7P15E5P |
| laxative | POLYETHYLENE GLYCOL 3350 | Rite Aid Corporation | 3ebe9191-8e0a-41cf-b759-82ecce4f50e4 | 2023-02-10 | Warnings | ANDA090685 876193 G2M7P15E5P |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | G2M7P15E5P |
| dg health clearlax | POLYETHYLENE GLYCOL 3350 | Dolgencorp, LLC | 94280ce4-b2cf-451d-a660-b26ab1a2d3f0 | 2023-02-06 | Warnings | ANDA090685 876193 G2M7P15E5P |
| clearlax | POLYETHYLENE GLYCOL 3350 | H E B | 0b4b752d-045d-4ff0-8e50-5607d1a841a7 | 2023-01-26 | Warnings | ANDA090685 876193 G2M7P15E5P |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | 435db89c-1e32-4da5-b7d0-15e407162715 | 2023-01-24 | Warnings | ANDA090685 876193 G2M7P15E5P |
| basic care clearlax | POLYETHYLENE GLYCOL 3350 | Amazon.com Services LLC | 21897170-0d5e-4326-bebf-10258e0aca82 | 2022-12-08 | Warnings | ANDA090685 876193 G2M7P15E5P |
| POLYETHYLENE GLYCOL 3350 | POLYETHYLENE GLYCOL 3350 | Geri-Care Pharmaceutical Corp | f4c7eb80-d8d5-406d-90d0-9d17914d71f2 | 2022-11-24 | Warnings | 876193 G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Gericare Pharmaceuticals | 5d0d2c14-24e6-45b4-92f6-4eaf5da72cdd | 2022-10-28 | Warnings | 876193 G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.